老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ATAI Life Sciences B.V.*

2.23
-0.0200-0.89%
成交量：148.66万
成交额：334.14万
市值：4.48亿
市盈率：-2.39
高：2.30
开：2.26
低：2.20
收：2.25
数据加载中...
总览公司新闻公告
2021/06/08

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/04

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/27

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/24

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/05/24

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/05/11

SEC问询函

CORRESP [Cover] - Correspondence
2021/05/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/20

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/20

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/24

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/29

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/15

超过5%披露

General statement of acquisition of beneficial ownership
2019/08/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多